Kertas Basuki Rachmat Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kertas Basuki Rachmat Indonesia Tbk. trades at Rp50 (market cap 434.4B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Kertas Basuki Rachmat Indonesia Tbk. is far larger — about 2.6× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| KBRI | OBAT | |
|---|---|---|
Market Cap | 434.4B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.
Read more on KBRI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →